School of Medicine
Showing 1-100 of 169 Results
-
Jason Andrews
Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Brian T. Bateman
Anesthesiology, Perioperative and Pain Medicine Professor and Professor, by courtesy, of Epidemiology and Population Health
BioBrian T. Bateman, MD, MSc is the Anesthesiology, Perioperative and Pain Medicine Endowed Professor and Chair of the Department of Anesthesiology, Perioperative, and Pain Medicine.
Before coming to Stanford, Dr. Bateman served as the Vice Chair for Faculty Development and Chief of the Division of Obstetric Anesthesia in the Department of Anesthesiology, Perioperative and Pain Medicine at the Brigham and Women’s Hospital/Harvard Medical School and as Co-Director of the Harvard Program on Perinatal and Pediatric Pharmacoepidemiology in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital.
Dr. Bateman’s scholarship focuses on the study of medication safety in pregnancy and on predictors and management of maternal morbidity. To address questions in these areas, Dr. Bateman and collaborators at Harvard helped pioneer the use of advanced epidemiological techniques applied to large, routinely collected healthcare utilization data. This research has been funded by multiple R01 grants from the NIH and by grants from the FDA and has been published in leading clinical journals including NEJM, JAMA, BMJ, Lancet, Annals of Internal Medicine, JAMA Pediatrics, JAMA Psychiatry, and Obstetrics and Gynecology. Dr. Bateman’s bibliography contains over 300 publications. This research is frequently cited in clinical reviews and guidelines and has prompted both the FDA and EMA to make labelling changes to medications regarding use in pregnancy. Dr. Bateman is also a founding member of the International Pregnancy Safety Study Consortium (InPress) which is a collaborative effort between investigators from the US and each of the five Nordic countries to pool data for studies evaluating the safety of medications.
Dr. Bateman currently serves as Chairperson of FDA’s Anesthetic and Analgesic Drug Products Advisory Committee after having previously served a 4-year term (2015-2019) as a voting member of this Committee. He was a technical advisor for the recent revision of the Joint Commission’s pain management standards. He has served on expert panels and workshops sponsored by the National Academy of Medicine, the FDA, the NIH, the CDC, and the Department of Health and Human Services, and on multiple grant review committees for the NIH and other funders. He is an Editor for the journal, Anesthesiology, and the textbook, Chestnut’s Obstetric Anesthesia: Principles and Practice.
Dr. Bateman’s work has been recognized by a number of awards including his selection in 2017 by the Society for Obstetric Anesthesia and Perinatology as the Gerard Ostheimer lecturer and in 2018 by the American Society of Anesthesiologists as the James E. Cottrell Presidential Scholar Awardee, which is given to one clinical-scientist each year within 10 years of initial faculty appointment for accomplishment in research.
Faculty development and mentorship has been a central focus of Dr. Bateman’s career. He has mentored numerous trainees who have gone on to outstanding academic careers. Throughout his career, he has worked particularly hard to advance the careers of women and underrepresented minorities and to create environments where everyone is welcomed and has an opportunity to advance.
Dr. Bateman is a Phi Beta Kappa graduate Yale College and received his MD from Columbia University College of Physicians & Surgeons, where he was a member of Alpha Omega Alpha and was awarded the Janeway Prize for the highest achievements and abilities in the graduating class. He completed an internship in internal medicine at Brigham and Women’s Hospital and residency and chief residency in anesthesiology at the Massachusetts General Hospital. He completed a Masters in Epidemiology at the Harvard School of Public Health. -
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
Suzan L Carmichael, PhD, MS
Professor (Research) of Pediatrics (Neonatology), of Obstetrics & Gynecology (Maternal Fetal Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Carmichael is a perinatal and nutritional epidemiologist and Professor of Pediatrics and Obstetrics and Gynecology at the Stanford University School of Medicine.
Her team is committed to finding ways to improve maternal and infant health outcomes and equity by leading research that identifies effective leverage points for change, from upstream 'macro' social and structural factors, to downstream clinical factors (eg, related to care and morbidities) through a collaborative research approach that integrates epidemiologic approaches with community engagement and systems thinking.
Exposure themes include social context, nutrition, care, environmental contaminants and genetics. Outcome themes include severe maternal morbidity, stillbirth, birth defects, and preterm delivery. She is particularly interested in understanding the intersectionality of these varied types of exposures and outcomes and how they interact to impact health and health disparities, for the mother-baby dyad.
Please see the team web-site for further information!
https://med.stanford.edu/carmichaellab.html -
Glenn M. Chertow
Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy
Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Mariame D. Diabate, PhD
Postdoctoral Scholar, Epidemiology
BioMariame Diabate, PhD (she/her) is a postdoctoral scholar in the HIPE Lab (Healthcare Innovation, Policy and Equity), mentored by Dr. Alyce S. Adams in the Stanford Cancer Institute and the Departments of Health Policy/Epidemiology and Population Health, and Pediatrics (by courtesy) and Dr. Tainayah Thomas in the Department of Epidemiology and Population Health. A two-time Buckeye, she earned her PhD in Biomedical Sciences and BS in Biology with a minor in Global Public Health from The Ohio State University. Dr. Diabate uses bioinformatics to study breast and ovarian cancer variants, intending to reduce cancer treatment disparities for minority women.
Through her postdoctoral training, she aims to address the genetic, social, and policy drivers of persistent health disparities. Dr. Diabate is currently focused on integrating community perspectives into observational research to improve population health outcomes and influence health policy. Additionally, she applies AI technology to support better treatment decisions, working alongside interdisciplinary teams to close the gap between cancer research and marginalized communities, while advocating for equitable healthcare.
Previously, she served as the youngest state-level commissioner on Ohio’s New African Immigrant Commission and interned with UNAIDS in Geneva, Switzerland. Currently, Dr. Diabate is one of the co-presidents for Stanford’s Black Postdoctoral Association. Her passion for improving minority women's health continues to drive her research and advocacy. -
Ellie Diamond
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioEllie holds a B.S. in Community Development & Applied Economics with a concentration in Community and International Development and Entrepreneurship from the University of Vermont. Ellie has previously worked as Research and Communications Fellow for Advance Vermont where she led the Vermont Credential Transparency Project. She also worked for the Vermont Department of Labor in the Economic and Labor Market Division, where she worked with interdisciplinary teams to develop and analyze a fringe benefits survey sent to Vermont Employers to learn more about wellness programs and incentives across the state. She also has experience as a medical assistant at a 3-physician internal medicine practice in Burlington, Vermont. Ellie enjoys running, cycling, and cross-country skiing.
-
Catherine Duarte
Instructor, Epidemiology and Population Health
BioDr. Catherine Duarte is an IDEAL Provostial Fellow based in the Department of Epidemiology & Population Health at Stanford University’s School of Medicine. She received her PhD in Epidemiology from the University of California, Berkeley School of Public Health and her Master of Science in Social and Behavioral Sciences from the Harvard T.H. Chan School of Public Health. As a doctoral student, Duarte was selected to the Robert Wood Johnson Foundation’s Health Policy Research Scholars Program - a national leadership training program bringing together scholars from across academic disciplines whose applied research seeks to contribute to building healthier and more equitable communities. Duarte’s work specifically focuses on examining how education and legal system policy and practices may shape racial health inequities throughout the life course. In so doing, her work aims to contribute to systems-level interventions designed to support health equity and wellbeing for collective thriving.
-
Raj Fadadu
Casual - Non-Exempt, Epidemiology and Population Health
BioRaj Fadadu is currently a dermatology resident physician at the University of California, San Diego. He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) as well as epigenetics (e.g., EWAS and epigenetic age acceleration). At Stanford, his research in Dr. Andres Cardenas's group focuses on the relationship between environmental exposures and epigenetic modifications. He also held leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.
He received a M.D. from UC San Francisco, M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health, and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors). -
Mohsen Fathzadeh
Genomic Scientist, Epidemiology and Population Health
BioMohsen Fathzadeh, a seasoned Medical Geneticist, has dedicated over 20 years to genomic science. His academic journey began at Yale University, where he completed his Ph.D. thesis under Prof. Arya Mani, focusing on a genetic form of familial Metabolic Syndrome. From 2015 to 2021, he served as a Postdoctoral Fellow at Stanford University, specializing in Cardiovascular Medicine, Psychiatry, and Public Health Sciences. During this tenure, he conducted comprehensive functional genomic analyses under the mentorship of esteemed professors.
Mohsen's collaborative efforts with Merck & Co., Inc. led to the identification of a gene regulator associated with body fat distribution. His research scope also includes the characterization of genes linked to insulin resistance and obesity. Recently, he explored the (epi)genetic link between newborn body fat distribution and high maternal gestational glucose levels, focusing on mother-child cohorts from diverse and underserved communities.
His primary goal is to utilize his findings to enhance our understanding of the genes and evolutionary pathways influencing healthspan and age-related diseases, thereby improving patient lives.
After completing his postdoctoral research in 2021, Mohsen spent two years in the biotech industry, specializing in genetic testing and variant assessment. He is currently affiliated with Stanford's Population Health Center, studying epigenetic disease mechanisms in mother-child cohorts.
Outside his professional life, Mohsen leads an active lifestyle and enjoys learning about diverse cultures. -
Vikram Fielding-Singh
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2024BioDr. Vikram Fielding-Singh is a Clinical Assistant Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. He obtained his medical degree from Stanford University and completed residency training at the University of California, San Francisco. He then pursued dual cardiac anesthesia and critical care training at the University of California, Los Angeles. He holds a juris doctorate from Yale Law School. Dr. Fielding-Singh’s research interests include improving perioperative care of patients with end stage kidney disease, using biomarkers to aid early diagnosis of acute kidney injury, and evaluating the performance of risk prediction models in perioperative medicine.
-
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
On Partial Leave from 07/15/2024 To 07/13/2025Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Shawna Follis
Instructor, Epidemiology and Population Health
BioShawna Follis, PhD, MS, is an Instructor and K99 Fellow in Epidemiology, researching the risk factors of cardiometabolic diseases. She completed her postdoctoral training at Stanford, as a Propel Postdoctoral Scholar from 2021 to 2023 and a NIH T32 Postdoctoral Fellow from 2020 to 2021. She received her PhD in epidemiology at the University of Arizona and her master’s degree in anthropology from Purdue University.
-
Rebecca M. Gardner
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2022
BioMy research interests are around hyperemesis gravidarum (HG), defined as severe nausea and vomiting during pregnancy that often leads to significant maternal undernutrition, and is one of the primary causes of hospitalization during pregnancy. I am interested in the link between HG and offspring outcomes, both around birth and into childhood; trends in antiemetic prescriptions; and whether certain environmental exposures exacerbate HG symptoms, leading to hospitalization.
Before starting a PhD, I was a biostatistician in the Quantitative Sciences Unit at Stanford for four years where I co-authored over thirty publications, collaborating with clinicians on various domains including developmental behavioral pediatrics, reproductive endocrinology & infertility, oncology, and clinical trials. I completed my MS in Statistics at Brigham Young University in 2016, where I collaborated with cardiologists to develop a new approach to diagnose rheumatic heart disease in pediatric patients in Samoa for my Master's thesis. -
Paul-Andre Genest
Adjunct Professor, Epidemiology and Population Health
BioDr. Paul-André Genest is an Assistant Director and Publisher at the American Chemical Society where he is responsible for the management of roughly a third of the ACS journals portfolio and Editorial Development team. Since 2016, he is an Adjunct Professor at Stanford University where he co-teaches a yearly course on scholarly communication (BIOS 292: Preparation and Practice: Scientific Communication & Media). Previously, he worked as a Publisher and Senior Editor at Wiley and as an Associate Publisher and Scientific Editor at Elsevier. Dr. Genest has a BSc (Biology) degree and a MSc (Microbiology-Immunology) degree from the Université Laval in Québec City, Canada, and a PhD (Molecular Parasitology) from the University of Amsterdam, The Netherlands. He held two postdoc research positions at the Netherlands Cancer Institute in Amsterdam, The Netherlands before transitioning to the scholarly publishing industry.
-
Nicole Gladish
Research Fellow, Epidemiology and Population Health
BioDr. Nicole Gladish is a Research Fellow in the Department of Epidemiology and Population Health at Stanford University. Her work integrates genetic, epigenetic, and population-level data to understand how biological and environmental factors interact to shape health disparities and influence trajectories of healthy aging. In addition to exploring molecular mechanisms, she conducts applied research on health policy interventions developing and refining tools like deprivation indices to inform equitable decision-making at the systems level.
Dr. Gladish earned her Ph.D. in Medical Genetics from the University of British Columbia (UBC), where her thesis focused on how early-life adversity, such as low socioeconomic status and abuse, affects DNA methylation patterns. This work aimed to elucidate the biological mechanisms that predispose individuals to chronic diseases such as cardiovascular disease, diabetes, and cancer.
At Stanford, she continues to investigate the interplay between social determinants and biological risk, with a growing emphasis on translational research. Her development of improved social deprivation indices supports more accurate identification of disadvantaged communities, informing public health funding, service allocation, and structural interventions across the U.S.
Dr. Gladish's work bridges molecular epidemiology and public policy, aiming to ensure that scientific insights translate into measurable improvements in population health. -
Steven Goodman
Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsI study issues relating to the representation and measurement of evidence in medical research and determinants of the reliability of biomedical research findings. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.
-
Bonnie Halpern-Felsher
Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry)
Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.
-
Cellas Ari'ka Hayes
Postdoctoral Scholar, Epidemiology
BioCellas is currently a postdoctoral fellow/Propel scholar at Stanford University in the Department of Neurology and Neurological Sciences in a laboratory utilizing longitudinal data analysis and neuroimaging modalities to understand the aging brain, neuropathology, cognition, and Alzheimer’s Disease. Postdoctoral experience includes using R, Linux, and Python to perform data preprocessing, multivariate statistical analysis, and applying novel models for longitudinal continuous outcomes. Cellas received his Bachelor’s in Biology (2015-2019) and Doctor of Philosophy in Pharmaceutical Sciences with an emphasis in Pharmacology (2019-2022) from the University of Mississippi. As a doctoral candidate, his research focused on using both in vitro and in vivo approaches to further elucidate how neuroendocrine modulation specifically insulin-like growth factor-1 alters learning and memory performance along with ischemic stroke outcomes. Skills gained during doctoral training included in vitro cell culture, pharmacological experimental design of both in vitro and in vivo studies, development of transgenic mouse models, a wide array of rodent behavioral paradigms, stereotaxic surgery, photothrombosis, and numerous ex vivo cellular, molecular, and microscopy techniques.
My primary interests lie at the intersection of aging, neurodegenerative disease, and using longitudinal epidemiological data sets to investigate hypotheses. All around neuroscientist seeking sci-comm, industry, and academic opportunities to strengthen skills to become an independent investigator. -
Victor W. Henderson, MD, MS
Professor of Epidemiology and Population Health and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsResearch interests:
(1) Risk factors for age-associated cognitive decline and for dementia.
(2) Therapeutic strategies to improve cognitive abilities in aging and in dementia.
(3) Brain–behavior relations as they pertain to human cognition. -
Ann Hsing
Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and of Epidemiology and Population Health
Current Research and Scholarly InterestsResearch Focus
• Epidemiology of prostate, hepatobiliary, and thyroid cancers
• Racial disparities in cancer
• Endogenous hormones/growth factors
• Circadian rhythms
• Chronic inflammation
• Genetic susceptibility
• Cancer prevention and control
• Global oncology and international studies -
Amy M Inkster
Postdoctoral Scholar, Epidemiology
BioAmy Inkster, PhD is a Postdoctoral Scholar in the Department of Epidemiology and Population Health at Stanford University. She conducts research on epigenetic alterations in pregnancy and early life to understand the molecular levers affecting healthy development. She primarily uses large 'omics datasets to study the effect of environmental exposures on pregnancy outcomes and maternal health.
Dr. Inkster received her PhD in Medical Genetics from the University of British Columbia (Vancouver, Canada), where her research focused on evaluating DNA methylation variation in prenatal life, primarily in the context of placental epigenetics, sex differences, prenatal exposures, and X-chromosome inactivation. She holds a BSc in Chemistry. As a cross-disciplinary researcher, her work and research interests lie at the intersection of molecular mechanisms and their impacts on human health and disease at the population level. -
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research Center), of Epidemiology and Population Health and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Esther M. John
Professor (Research) of Epidemiology and Population Health and of Medicine (Oncology)
Current Research and Scholarly InterestsDr. John has extensive expertise in conducting population-based epidemiologic studies and has led as Principal Investigator multiple large-scale studies, including multi-center studies with a study site in the San Francisco Bay Area with its diverse population. Many of her studies and collaborations investigated cancer health disparities. Her research has focused on the role of modifiable lifestyle factors (e.g., body size, physical activity, diet), hormonal factors, early-life exposures, genetic variants, and gene-environment interactions; differences in risk factors by race and ethnicity, breast cancer subtypes, and prostate cancer subtypes; risk factors for familial breast cancer and second primary breast cancer, as well as prognostic factors related to survival disparities.
As Principal Investigator, Dr. John has led a number of studies conducted in the San Francisco Bay Area, including:
- the Northern California site of the Breast Cancer Family Registry, an on-going prospective multi-generational cohort of over 13,000 families established in 1995 at six international sites;
- the San Francisco Bay Area Breast Cancer Study, a population-based case-control study in nearly 5,000 African American, Hispanic, and non-Hispanic White women that investigated the role of modifiable lifestyle factors and other risk factors;
- the California site of the Breast Cancer Health Disparities Study that investigated genetic variability and breast cancer risk and survival in Hispanic and non-Hispanic White populations in the context of genetic admixture;
- the Breast Cancer Etiology in Minorities (BEM) Study, a pooled analysis of risk factors for breast cancer subtypes in minoritized racial and ethnic populations;
- the Northern California site of the WECARE Study that investigates risk factors for second primary contralateral breast cancer;
- the Second Primary Breast Cancer Disparities Study, a pooled analysis of risk factors for contralateral and ipsilateral second primary breast cancer in a diverse population;
- the San Francisco Bay Area Prostate Cancer Study, a population-based case-control study of lifestyle and genetic risk factors for advanced and localized disease.
These studies collected and pooled extensive data and biospecimens and continue to support numerous ancillary studies, collaborations and international consortia and have contributed to a better understanding of cancer risk and survival in minoritized racial and ethnic populations.
Dr. John is a founding PI of the LEGACY Girls Study, a prospective cohort established in 2011 that investigates early life exposures in relation to pubertal development outcomes, breast tissue characteristics, and behavioral and psychosocial outcomes in the context of having a family history or breast cancer.
In 2023, Dr. John joined the Stanford investigator team of the MOSAAIC (The Multiethnic Observational Study in American Asian and Pacific Islander Communities) Study, a five-center study to improve health of American Asian, Native Hawaiian, and Pacific Islander populations. -
Ankita Kaulberg
Head of Product, Our Voice Platform, Epidemiology and Population Health
Current Role at StanfordHead of Product, Our Voice Platform
Stanford School of Medicine -
Mathew Kiang
Assistant Professor of Epidemiology and Population Health (Epidemiology)
BioI am an assistant professor in the Department of Epidemiology and Population Health. My research lies at the intersection of computational epidemiology and social epidemiology. Methodologically, my work revolves around combining disparate data sources in epidemiologically meaningful ways. For example, I work with individual-level, non-health data (e.g., GPS, accelerometer, and other sensor data from smartphones), traditional health data (e.g., survey, health systems, or death certificate data), and third-party data (e.g., cellphone providers or ad-tech data). To do this, I use a variety of methods such as joint Bayesian spatial models, traditional epidemiologic models, dynamical models, microsimulation, and demographic analysis. Substantively, my work focuses on socioeconomic and racial/ethnic inequities. For example, recently, my work has examined inequities in COVID-19 vaccine distribution, cause-specific excess mortality, and drug poisonings. I have an NIDA-funded R00 examining equitable ways to improve treatment for opioid use disorder across structurally disadvantaged groups and am Co-I on a NIDA-funded R21 examining ways to use novel data sources (such as social media) to predict surges in opioid-related mortality.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Angelle Desiree LaBeaud
Professor of Pediatrics (Infectious Diseases), Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Epidemiology and Population Health and of Environmental Social Sciences
Current Research and Scholarly InterestsArthropod-borne viruses are emerging and re-emerging infections that are spreading throughout the world. Our laboratory investigates the epidemiology of arboviral infections, focusing on the burden of disease and the long-term complications on human health. In particular, Dr. LaBeaud investigates dengue, chikungunya, and Rift Valley fever viruses in Kenya, where outbreaks cause fever, arthritis, retinitis, encephalitis, and hemorrhagic fever. Our main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections. Our laboratory also investigates the effects of antenatal and postnatal parasitic infections on vaccine responses, growth, and development of Kenyan children.
My lab at Stanford supports the field work that is ongoing in Kenya, but we also have several projects that are based locally. We strive to improve diagnostics of arboviral infections and are using Luminex technology to build a new screening assay. We also have created a Luminex based platform to assess vaccine responses against multiple pathogens. -
Tracy Lam-Hine
Postdoctoral Scholar, Epidemiology
BioTracy Lam-Hine (he/him), DrPH, MBA, is a postdoctoral scholar in the Department of Epidemiology and Population Health and the Center for Population Health Sciences, and a T32 trainee in the Division of Endocrinology, Gerontology, and Metabolism. Dr. Lam-Hine is a social and legal epidemiologist, studying how exposure to adverse childhood experiences and policy environments shape the risk of chronic disease and aging outcomes across the life course. Within this broad research area, he has a special focus on the health and social experiences of the US Multiracial population and the measurement of structural racism in policy. Dr. Lam-Hine also collaborates with state and local health jurisdictions in California and Hawaii in applied epidemiology and surveillance projects on topics including structural racism, adolescent health, and COVID-19.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health and, by courtesy, of Urology
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a healthcare lead and physician scientist for innovation, R&D, and advanced analytics, and oversee these aspects at VA Palo Alto/VHA, within Stanford-VA relationship. The VA has the US's largest health care system and longest running EHR. I prioritize enabling multiple partners (industry, government, academia, foundations), to innovate/R&D in the VA health care system. We prioritize mentoring students from various Schools to become future leaders in R&D, innovation, and healthcare.
-
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
-
Eleni Linos, MD, MPH, DrPH
Ben Davenport and Lucy Zhang Professor of Medicine, Professor, of Medicine (Center for Digital Health) and, by courtesy, of Epidemiology and Population Health
BioEleni Linos MD, MPH, DrPH, is the Director of the Stanford Center for Digital Health. She is a Professor of Dermatology and Epidemiology at Stanford University. Dr. Linos also serves as an Associate Dean for Research, leading the KL2 Research Training Program.
Dr. Linos' research focuses on the use of technology in health, dermatology, public health, cancer prevention and the care of older adults. She is dually trained in epidemiology and dermatology and is the principal investigator of several NIH funded studies aimed at improving the lives of patients. She received her medical degree from Cambridge and Oxford universities in the UK, received a masters and doctoral degree from the Harvard School of Public Health and completed her residency at Stanford. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms. -
Ying Lu
Professor of Biomedical Data Science and, by courtesy, of Epidemiology
Current Research and Scholarly InterestsBiostatistics, clinical trials, statistical evaluation of medical diagnostic tests, radiology, osteoporosis, meta-analysis, medical decision making
-
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.
-
David Maahs
Lucile Salter Packard Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health
BioDr David M. Maahs is the Lucile Salter Packard Professor of Pediatrics, Division Chief of Pediatric Endocrinology, and Associate Chair for Academic Affairs in Pediatrics at Stanford University and the Lucile Packard Children’s Hospital. He earned his MD followed by Pediatric Residency at the University of New Mexico. After 3 years on New Mexico’s faculty, Dr. Maahs completed a Pediatric Endocrinology fellowship and a concurrent PhD in Epidemiology at the University of Colorado. He remained on Colorado’s faculty for 10 years, advancing to Professor of Pediatrics before moving to Stanford. Prior to his medical career, Dr. Maahs received a BA and MA in English from the University of Kansas and was inspired to pursue a medical career after serving in the Peace Corps with assignments in Tunisia and the Central African Republic.
Dr. Maahs’ leadership experiences include being a past co-Chair (2013-16) for Protocols and Publications with the Type 1 Diabetes Exchange for which he continues as Director of International Collaborations. This complements his role as President-elect for the International Society of Pediatric and Adolescent Diabetes (ISPAD, 2021-25) and Editor-in-Chief for the 2018 ISPAD Clinical Practice Consensus Guidelines. He served on the Professional Practice Committee for the American Diabetes Association (ADA, 2016-18), which writes the annual ADA Standards of Care. Previously, he served on the ADA Scientific Sessions committee representing the Council on Youth. He has also served on national committees for the American Heart Association, the Pediatric Endocrine Society, and multiple journal editorial boards and review committees.
His scholarly interest is improving care and preventing complications in people with type 1 diabetes (T1D). Along with Dr Peter Chase, he is author of the 12th and 13th editions of Understanding Diabetes, or ‘Pink Panther,’ which are the most widely used educational books for children newly diagnosed with T1D, distributed internationally by the Juvenile Diabetes Research Fund (JDRF). More specifically, he has conducted epidemiologic studies that help generate hypotheses for clinical studies, including trials to develop artificial pancreas systems to improve glucose control, lower disease burden, prevent the complications of diabetes, and reduce disparities in diabetes care. He is author or co-author of over 350 research publications. His multi-disciplinary research has been funded by the JDRF, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), the Helmsley Charitable Trust, and the National Science Foundation (NSF).
Dr Maahs is Associate Director for the recently formed and NIDDK P30 funded Stanford University Diabetes Research Center (https://sdrc.stanford.edu). His collaborations extend to his role as Principal Investigator (PI) or steering committee member for NIH funded multi-center clinical trials including the FLEX, PERL, and ACTION studies as well as multiple Artificial Pancreas clinical trials. Education, mentorship, and training leadership includes being Program Director with Dr. Georgeanna Klingensmith on the Barbara Davis Center T32 and K12 training grants in Pediatric Endocrinology while at the University of Colorado. He is the PI on the Stanford NIH funded K12 "Training Research Leaders in Type 1 Diabetes.' Dr Maahs is also the Associate Chair for Academic Affairs for the Department of Pediatrics.
While in the Peace Corps, David met his wife, Christine Walravens, who is also a Pediatrician at Stanford. They enjoy outdoor activities and traveling with their adult children. -
Mario Malički
Social Science Research Scholar, Epidemiology and Population Health
Current Role at StanfordAssociate Director of Stanford Program of Research Rigor and Reproducibility (SPORR)
